Table 2

End-of-life (EOL) care in patients with oxygen-dependent interstitial lung disease (ILD) versus lung cancer

ILD
n=285
Lung cancer
n=10 822
p Value
2 test)
Expected death
 Unexpected41 (15)454 (4)<0.001
 Expected235 (82)10 205 (94)<0.001
 Unknown9 (3)163 (2)0.026
Place of death
 Hospice/palliative hospital ward23 (8)2988 (27)<0.001
 Hospital ward, not palliative130 (46)3964 (37)0.098
 Nursing home50 (17)746 (7)<0.001
 Specialised palliative home care26 (9)1421 (13)0.001
 General palliative home care27 (10)529 (5)0.025
 Short-term care home25 (9)1108 (10)0.010
 Other4 (1)66 (1)0.254
EOL discussion with patient117 (41)6337 (59)<0.001
EOL discussion with family148 (52)7923 (73)<0.001
Died in preferred place of death116 (41)5166 (48)0.019
Palliative care team consultation14 (6)1215 (19)0.655
Next of kin present at death98 (34)4532 (42)0.006
Use of validated symptom scale for pain38 (13)3024 (28)<0.001
Use of validated symptom scale for other symptoms23 (8)1518 (14)0.004
Use of parenteral fluids/nutrition during the last day41 (14)1526 (14)0.891
  • Figures are numbers (percentage) unless stated otherwise.